Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Furosemide | 1 | 2019 | 174 | 0.610 |
Why?
|
Diuretics | 1 | 2019 | 614 | 0.510 |
Why?
|
Heart Failure | 10 | 2024 | 11879 | 0.430 |
Why?
|
Heart Transplantation | 4 | 2024 | 3301 | 0.330 |
Why?
|
Multiple Organ Failure | 1 | 2009 | 388 | 0.280 |
Why?
|
Natriuretic Agents | 1 | 2004 | 57 | 0.240 |
Why?
|
Hemochromatosis | 1 | 2021 | 175 | 0.170 |
Why?
|
Infusions, Subcutaneous | 1 | 2019 | 43 | 0.160 |
Why?
|
Glomerular Filtration Rate | 2 | 2024 | 2227 | 0.160 |
Why?
|
Graft Rejection | 2 | 2009 | 4492 | 0.150 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2022 | 560 | 0.130 |
Why?
|
Palliative Care | 2 | 2023 | 3643 | 0.130 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2004 | 1751 | 0.130 |
Why?
|
Dogs | 1 | 2019 | 3845 | 0.110 |
Why?
|
Bariatric Surgery | 1 | 2024 | 1001 | 0.110 |
Why?
|
Cause of Death | 1 | 2004 | 3721 | 0.110 |
Why?
|
Heart-Assist Devices | 1 | 2004 | 1292 | 0.110 |
Why?
|
Obesity, Morbid | 1 | 2024 | 1298 | 0.100 |
Why?
|
Iron | 1 | 2021 | 1813 | 0.100 |
Why?
|
Hospice Care | 1 | 2019 | 678 | 0.100 |
Why?
|
Acute Kidney Injury | 1 | 2024 | 1942 | 0.100 |
Why?
|
Laparoscopy | 1 | 2024 | 2041 | 0.100 |
Why?
|
Hemodynamics | 1 | 2022 | 4194 | 0.100 |
Why?
|
Blood Pressure | 1 | 2006 | 8543 | 0.090 |
Why?
|
Acute Disease | 2 | 2019 | 7243 | 0.080 |
Why?
|
Coronary Artery Disease | 1 | 2009 | 6568 | 0.080 |
Why?
|
Survival Rate | 3 | 2009 | 12840 | 0.080 |
Why?
|
Retreatment | 1 | 2009 | 598 | 0.070 |
Why?
|
Patient Readmission | 1 | 2019 | 3288 | 0.060 |
Why?
|
Treatment Outcome | 5 | 2024 | 65371 | 0.060 |
Why?
|
Kidney Function Tests | 1 | 2007 | 684 | 0.060 |
Why?
|
Cardiac Output | 1 | 2006 | 838 | 0.060 |
Why?
|
Biological Availability | 1 | 2004 | 389 | 0.060 |
Why?
|
Multivariate Analysis | 2 | 2009 | 12077 | 0.050 |
Why?
|
Heart Function Tests | 1 | 2004 | 317 | 0.050 |
Why?
|
Renal Replacement Therapy | 1 | 2024 | 282 | 0.050 |
Why?
|
Maximum Tolerated Dose | 1 | 2004 | 899 | 0.050 |
Why?
|
Diabetes Mellitus | 3 | 2021 | 5889 | 0.050 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2004 | 640 | 0.050 |
Why?
|
Prevalence | 1 | 2019 | 15869 | 0.050 |
Why?
|
Cardiac Resynchronization Therapy Devices | 1 | 2022 | 122 | 0.050 |
Why?
|
Brain Death | 1 | 2024 | 359 | 0.050 |
Why?
|
Neoplasms | 1 | 2009 | 22371 | 0.040 |
Why?
|
Iron Chelating Agents | 1 | 2021 | 141 | 0.040 |
Why?
|
Retrospective Studies | 6 | 2024 | 81762 | 0.040 |
Why?
|
Transferrin | 1 | 2021 | 283 | 0.040 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2004 | 879 | 0.040 |
Why?
|
Kidney | 2 | 2024 | 7064 | 0.040 |
Why?
|
Oxygen Consumption | 1 | 2006 | 1880 | 0.040 |
Why?
|
Hypotension | 1 | 2006 | 888 | 0.040 |
Why?
|
Gastrectomy | 1 | 2024 | 693 | 0.040 |
Why?
|
Incidence | 2 | 2024 | 21538 | 0.040 |
Why?
|
Probability | 1 | 2004 | 2479 | 0.040 |
Why?
|
Confidence Intervals | 1 | 2004 | 2923 | 0.040 |
Why?
|
Middle Aged | 9 | 2024 | 223492 | 0.040 |
Why?
|
Humans | 14 | 2024 | 768166 | 0.040 |
Why?
|
Edema | 1 | 2021 | 765 | 0.040 |
Why?
|
Aftercare | 1 | 2023 | 916 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2021 | 1836 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2004 | 4860 | 0.030 |
Why?
|
Immunosuppressive Agents | 1 | 2009 | 4206 | 0.030 |
Why?
|
Leg | 1 | 2021 | 1088 | 0.030 |
Why?
|
Tissue and Organ Procurement | 1 | 2024 | 986 | 0.030 |
Why?
|
Survival Analysis | 2 | 2005 | 10101 | 0.030 |
Why?
|
Tissue Donors | 1 | 2024 | 2381 | 0.030 |
Why?
|
Male | 9 | 2024 | 364719 | 0.030 |
Why?
|
Fatigue | 1 | 2021 | 1557 | 0.030 |
Why?
|
Pulmonary Artery | 1 | 2022 | 1946 | 0.030 |
Why?
|
Aged | 4 | 2024 | 171504 | 0.030 |
Why?
|
Graft Survival | 1 | 2004 | 3887 | 0.030 |
Why?
|
Arrhythmias, Cardiac | 1 | 2022 | 2258 | 0.030 |
Why?
|
Time Factors | 2 | 2024 | 40218 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2004 | 10760 | 0.030 |
Why?
|
Weight Loss | 1 | 2024 | 2721 | 0.020 |
Why?
|
Female | 8 | 2024 | 397192 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2023 | 3620 | 0.020 |
Why?
|
Patient Discharge | 1 | 2023 | 3479 | 0.020 |
Why?
|
Prognosis | 3 | 2006 | 30010 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2006 | 15948 | 0.020 |
Why?
|
Exercise | 1 | 2006 | 5955 | 0.020 |
Why?
|
Heart | 1 | 2022 | 4446 | 0.020 |
Why?
|
Cardiomyopathies | 1 | 2021 | 2056 | 0.020 |
Why?
|
Registries | 1 | 2004 | 8375 | 0.020 |
Why?
|
Adult | 3 | 2024 | 223646 | 0.020 |
Why?
|
Animals | 1 | 2019 | 169246 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2021 | 13014 | 0.020 |
Why?
|
Body Mass Index | 1 | 2024 | 13053 | 0.020 |
Why?
|
Cohort Studies | 2 | 2007 | 41754 | 0.020 |
Why?
|
Risk Assessment | 1 | 2004 | 24315 | 0.010 |
Why?
|
Quality of Life | 1 | 2023 | 13490 | 0.010 |
Why?
|
Creatinine | 1 | 2007 | 1918 | 0.010 |
Why?
|
Risk Factors | 2 | 2024 | 74944 | 0.010 |
Why?
|
Diabetic Angiopathies | 1 | 2005 | 806 | 0.010 |
Why?
|
Reference Values | 1 | 2007 | 4938 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2004 | 59629 | 0.010 |
Why?
|
Exercise Test | 1 | 2006 | 2186 | 0.010 |
Why?
|
Myocardial Ischemia | 1 | 2007 | 2138 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2006 | 5315 | 0.010 |
Why?
|
Ventricular Function, Left | 1 | 2006 | 3941 | 0.010 |
Why?
|
Prospective Studies | 2 | 2006 | 54926 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2005 | 12543 | 0.010 |
Why?
|
Disease Progression | 1 | 2005 | 13671 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 2006 | 39348 | 0.000 |
Why?
|
Concepts
(103)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(20)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_